Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care ∗
Velazquez EJ, Reinhardt SW. Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care ∗. Journal Of The American College Of Cardiology 2020, 76: 2086-2088. PMID: 33121715, DOI: 10.1016/j.jacc.2020.09.538.Commentaries, Editorials and LettersCanagliflozinCardiovascular DiseasesHeart Disease Risk FactorsHeart FailureHumansNatriuretic Peptide, BrainNatriuretic PeptidesPeptide FragmentsRisk FactorsSodium-Glucose Transporter 2 Inhibitors